Showing results (231-240 of 274) with videos related to
Sort By:
Pageof 28
Frontiers in Psychiatry|July 19, 2021
Comparative Characteristics of the Metabolic Syndrome Prevalence in Patients With Schizophrenia in Three Western Siberia Psychiatric HospitalsElena G Kornetova, Alexander N Kornetov, Irina A Mednova, et al.Problemy Tuberkuleza I Boleznei Legkikh|October 8, 2005
[Use of biological microchips in the determination of drug-resistance of Mycobacterium tuberculosis to rifampicin]Zh T Isakova, O A Pak, E Iu Iusupova, et al.BMC Medical Genomics|March 6, 2018
Novel candidate genes important for asthma and hypertension comorbidity revealed from associative gene networksOlga V Saik, Pavel S Demenkov, Timofey V Ivanisenko, et al.Current Protocols in Cytometry|October 11, 2016
Automated Measurement of Blood Vessels in Tissues from Microscopy ImagesNeil J Kelly, Nadine Dandachi, Dmitry A Goncharov, et al.Circulation|January 28, 2016
SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection FractionYen-Chun Lai, Diana M Tabima, John J Dube, et al.Biorxiv : the Preprint Server for Biology|November 26, 2025
Lactate dehydrogenase-induced DNA Topoisomerase 1 is a novel regulator of smooth muscle cell proliferation and remodeling in pulmonary arterial hypertensionLifeng Jiang, Iryna Zhyvylo, Dmitry Goncharov, et al.Genes|July 27, 2022
The Gender-Specific Association of DRD2 Polymorphism with Metabolic Syndrome in Patients with SchizophreniaDiana Z Paderina, Anastasiia S Boiko, Ivan V Pozhidaev, et al.Biomeditsinskaia Khimiia|November 1, 2018
[Comparative analysis of gene expression in vascular cells of patients with advanced atherosclerosis]M S Nazarenko, A V Markov, A A Sleptsov, et al.Molekuliarnaia Genetika, Mikrobiologiia I Virusologiia|July 18, 2015
[MICROBIAL COMMUNITIES ON KIDNEY STONES]Yu M Romanova, N S Mulabaev, E R Tolordava, et al.American Journal of Respiratory and Critical Care Medicine|September 14, 2018
Toll-like Receptor 3 Is a Therapeutic Target for Pulmonary HypertensionDaniela Farkas, A A Roger Thompson, Aneel R Bhagwani, et al.Pageof 28